 AMAG Pharmaceuticals NASDAQ:AMAG had its price objective increased by SVB Leerink from 9.00 to 10.00 in a research note issued to investors on Friday morning, BenzingaRatingsTable reports. The firm currently has a market perform rating on the specialty pharmaceutical companys stock. Several other equities analysts have also weighed in on AMAG. Zacks Investment Research upgraded ... 